Phenolics in the Tussilago farfara leaves

Justyna Chanaj-Kaczmarek 1 , Małgorzata Wojcińska 1 ,  and Irena Matławska 1
  • 1 Department of Pharmacognosy Poznań University of Medical Sciences Święcickiego 4 60-781 Poznań, Poland


Coltsfoot leaves (Farfarae folium) are used in the European medicine in respiratory tract diseases, for cough, bronchitis and asthmatic disorders, while in the traditional Chinese medicine only flower buds (Farfarae flos) have been recognized as a medicine. A short literature review shows that most data concern the chemical composition of the coltsfoot flowers. During the carried out studies we have isolated and identified (UV, 1H and 13C NMR, analysis of acid and enzymatic hydrolyze products) six known flavonols from the coltsfoot leaves: kaempferol and its 3-O-β-glucopyranoside and 3-O-α-rhamnopyranosyl(1→6)- β-glucopyranoside, along with quercetin derivatives: 3-O-β-arabinopyranoside, 3-O-β- glucopyranoside and 3-O-α-rhamnopyranosyl(1→6)-β-glucopyranoside. Moreover, we have detected the presence of three phenolic acids.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Liu YF, Yang XW, Wu B. Studies on chemical constituents in the buds of Tussilago farfara. China J Chinese Mat Med 2007; 32(22):2378-81.

  • 2. Wu D, Zhang M, Zhang C, Wang Z. Flavonoids and phenolic acid derivatives from Flos Farfarae. China J Chinese Mat Med 2010; 35(9):1142-4.

  • 3. Liu YF, Yang XW. HPLC fingerprint of chemical constituents of Flos Farfarae. Acta Pharm Sin 2009; 44(5):510-14.

  • 4. Didry N, Pinkas M, Torck M. Phenolic components from Tussilago farfara. Ann Pharm Fr 1980; 38:237-41.

  • 5. Olechowska-Barańska K, Lamer E. Identyfikacja oraz oznaczanie niektórych flawonoidów występujących w kwiatach podbiału. Acta Pol Pharm 1962; 19(3):199-207.

  • 6. Zhi HJ, Qin XM, Sun HF, Zhang LZ, Guo XQ, Li ZY. Metabolic fingerprinting of Tussilago farfara L. using (1) H-NMR spectroscopy and multivariate data analysis. Phytochem Anal 2012; 23(5):492-501.

  • 7. Li ZY, Zhi HJ, Xue SY, Sun HF, Zhang FS, Jia JP, Xing J, Zhang LZ, Qin XM. Metabolomic profiling of the flower bud and rachis of Tussilago farfara with antitussive and expectorant effects on mice. J Ethnopharmacol 2012; 140(1):83-90.

  • 8. Ryu JH, Jeong YS, Sohn DH. A new bisobolene epoxide from Tussilago farfara, and inhibition of nitric oxide synthesis in LPS-activated macrophages. J Nat Prod 1999; 62(10):1437-8.

  • 9. Yaoita Y, Kamzawa H, Kikuchi M. Structures of new oplopane-type sesquiterpenoids from the flower buds of Tussilago farfara L. Chem Pharm Bull 1999; 47(5):705-7.

  • 10. Yaoita Y, Suzuki N, Kikuchi M. Structures of new sesquiterpenoids from Farfarae Flos. Chem Pharm Bull 2001; 49(5):645-8.

  • 11. Liu LL, Yang JL, Shi YP. Sesquiterpenoids and other constituents from the flower buds of Tussilago farfara. J Asian Nat Prod Res 2011; 13(10):920-9.

  • 12. Li W, Huang X, Yang XW. New sesquiterpenoids from the dried flower buds of Tussilago farfara and their inhibition on NO production in LPS-induced RAW264.7 cells. Fitoterapia 2012; 83(2):318-22.

  • 13. Wu D, Zhang M, Zhang C, Wang Z. Chromones from the flower buds of Tussilago farfara. Biochem Syst Ecol 2008; 36(3):219-20.

  • 14. Liu Y, Yang X, Wu B. GC-MS analysis of essential oil constituents from buds of Tussilago farfara L. Journal of Chinese Pharmaceutical Sciences 2006; 15(1):10-14.

  • 15. Kopp B. Pyrrolizidine alkaloid (PA)-free coltsfoot leaves. Part 1. In vitro cultivation and selection culture. Deutsche Apotheker-Zeitung (Germany) 1997; 137:44-7.

  • 16. Hirono I, Mori H, Culvenor C. Carcinogenic activity of coltsfoot, Tussilago farfara L. Gann. 1976; 67(1):125-9.

  • 17. Hwang SB, Chang MN, Garcia ML, Han QQ, Huang LY, King VF, Kaczorowski GJ, Winquist RJ. L-652,469-a dual receptor antagonist of platelet activating factor and dihydropyridines from Tussilago farfara L. Eur J Pharmacol. 1987; 141:269.

  • 18. Kim MR, Lee JY, Lee HH, Aryal DK, Kim YG, Kim SK, Woo ER, Kang KW. Antioxidative effects of quercetinglycosides isolated from the flower buds of Tussilago farfara L. Food Chem Toxicol. 2006; 44(8):1299-307.

  • 19. Cho J, Kim HM, Ryu JH, Jeong YS, Lee YS, Jin C. Neuroprotective and antioxidant effects of the ethyl acetate fraction prepared from Tussilago farfara L. Biol Pharm Bull. 2005; 28(3):455-60.

  • 20. Hwangbo C, Lee HS, Park J, Choe J, Lee JH. The anti-inflammatory effect of tussilagone, from Tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages. Int Immunopharmacol 2009; 9(13-14):1578-84.

  • 21. Bonjar S. Evaluation of antibacterial properties of some medicinal plants used in Iran. J Ethnopharmacol 2004; 94(2-3):301-5.

  • 22. Janovska D, Kubikova K, Kokoska L. Screening for antimicrobial activity of some medicinal plant specie of traditional Chinese medicine. Czech J Food Sci 2003; 21(3):107-10.

  • 23. Kokoska L, Polesny Z, Rada V, Nepovim A, Vanek T. Screening of some Siberian medicinal plants for antimicrobial activity. J Ethnopharmacol 2002; 82(1):51-3.

  • 24. Gao H, Huang Y, Gao B, Xu P, Inagaki C, Kawabata J. a-Glucosidase inhibitory effect by the flower buds of Tussilago farfara L. Food Chem 2008; 106(3):1195-201.

  • 25. Lim HJ, Lee HS, Ryu JH. Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression by tussilagone from Farfarae flos in BV-2 microglial cells. Arch Pharm Res 2008; 31(5):645-52.

  • 26. Park HR, Yoo MY, Seo JH, Kim IS, Kim NY, Kang JY, Cui L, Lee CS, Lee CH, Lee HS. Sesquiterpenoids isolated from the flower buds of Tussilago farfara L. inhibit diacylglycerol acyltransferase. J Agric Food Chem 2008; 56(22):10493-7.

  • 27. Mabry TJ, Markham KR, Thomas MB. The systematic of flavonoids. Springer-Verlag, New York 1970.

  • 28. Harborne TJ, Mabry H, Mabry TJ. The Flavonoids. Chapman & Hall, London 1975: 376-441.

  • 29. Markham KR. Techniques of Flavonoid Identification. Academic Press, London 1982.

  • 30. Wagner H, Bladt S. Plant Drug Analysis. A Thin Layer Chromatography Atlas. Springer-Verlag, Berlin, Heidelberg, New York 1996:195-244.

  • 31. Harborne JB. The Flavonoids: Advances in Research since 1986. Chapman and Hall. London 1994.

  • 32. Agrawal PK. Carbon-13 NMR of flavonoids. Elsevier Science Publishers. Amsterdam-Oxford-New York- Tokyo 1989.

  • 33. Agrawal PK. NMR spectroscopy in the structural elucidation of oligosaccharides and glycosides. Review Article Number 70. Phytochem 1992; 31(10):3307-3330.

  • 34. Markham KR, Ternai B, Stanley R, Geiger H, Mabry TJ. Carbon-13 NMR studies of flavonoids III. Naturally occurring flavonoid glycosides and their acylated derivatives. Tetrahedron 1978; 34:1389-1397.

  • 35. Harborne JB, Mabry TJ. The Flavonoids: Advances in Research. Chapman and Hall. London 1982.

  • 36. Ebadi M. Pharmacodynamic Basis of Herbal Medicine. CRC Press, Boca Raton, London 2002.

  • 37. Inaba H, Tagashira M, Honma D, Kanda T, Kou Y, Ohtake Y, Amano A. Identification of hop polyphenolic components which inhibit prostaglandin E2 production by gingival epithelial cells stimulated with periodontal pathogen. Biol Pharm Bull 2008; 31(3):527-530.

  • 38. Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, Singh T, Ha JH, Lee MG, Kim JE, Hyun MC, Kwon TK, Kim YG, Kim SH. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Archiv Pharm Res 2008; 31(10):1303-1311.

  • 39. Olas B, Wachowicz B, Stochmal A. Relationship between vasodilatation capacity and phenolics content of Spanish wines. Europ J Pharm 2005, 517(1-2):84-91.

  • 40. Ishikawa A, Yamashita H, Hiemori M, Inagaki E, Kimoto M, Okamoto M, Tsuji H, Memon AN, Mohammadio A, Natori Y. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) 2007; 53(2):166-73.


Journal + Issues